Ultragenyx Pharmaceutical Obtains FDA Accelerated Approval For GENGLYCOS In Adult And Pediatric Patients Eight Years And Older With Glycogen Storage Disease Type Ia

뉴스 본문을 불러오고 있어요.

Ultragenyx Pharmaceutical Obtains FDA Accelerated Approval For GENGLYCOS In Adult And Pediatric Patients Eight Years And Older With Glycogen Storage Disease Type Ia | 웨이프 WAPE

Ultragenyx Pharmaceutical Obtains FDA Accelerated Approval For GENGLYCOS In Adult And Pediatric Patients Eight Years And Older With Glycogen Storage Disease Type Ia

기사 요약

관련 종목

댓글 —